Toshihide Yokoyama

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.2K citations · Full text

TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells

Katsura Nozawa, Eri Kawabata-Shoda, Hitoshi Doihara et al. · Proceedings of the National Academy of Sciences · 2009 · 397 citations · Full text

Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer

Kohsuke Isomoto, Koji Haratani, Hidetoshi Hayashi et al. · Clinical Cancer Research · 2020 · 233 citations

A Phase 2 Study of Atezolizumab for Pretreated NSCLC With Idiopathic Interstitial Pneumonitis

Satoshi Ikeda, Terufumi Kato, Hirotsugu Kenmotsu et al. · Journal of Thoracic Oncology · 2020 · 96 citations · Full text

Translational Medicine, Antibiotics, Pretreated Nsclc +5

QGP-1 cells release 5-HT via TRPA1 activation; a model of human enterochromaffin cells

Hitoshi Doihara, Katsura Nozawa, Ryosuke Kojima et al. · Molecular and Cellular Biochemistry · 2009 · 70 citations

Trpa1 Activation, Qgp-1 Cells, Signal Transduction +10